Home
About
Company
Careers
Technology
Pipeline
Collaboration
News
Contact
Menu
Home
About
Company
Careers
Technology
Pipeline
Collaboration
News
Contact
Search
Close
中文
Menu
中文
News
Home
>
News
News
Asieris completed enrollment for its China Phase II Trial of APL-1202
Asieris won a Small to Medium-Size Technological Enterprise (SME) in Jiangsu
Dr. Kevin Pan was selected as a member of “113 Talent Program”
Dr. Yuh visited Nanjing iDatastat, the CRO for APL-1202’s China phase II trial
Asieris initiated TV interview for APL-1202 China phase 2 clinical trial
Asieris held an investigators’ meeting for APL-1202’s phase II clinical trial in China
Asieris achieved objectives in the grant of Supporting Science and Technology
Asieris presented at the fourth China (Taizhou) International Medical Expo
September 2012: Jiangsu FDA inspected APL-1202’s CRO
Asieris Pharmaceuticals establish collabration with US Chinese Anti-cancer Association
« Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next »